IL22 and Alzheimer disease: To assess the possible effect of allergen-specific CLA+ T-cell IL-22 response on the morphology and molecular signature of lesional skin as well as the clinical profile of AD, patients were stratified based on IL-22 secretion into IL-22 producers (IL22P; n=17) and non-producers (IL22NP; n=41) (Figure 1A).